Ubs Asset Management Americas Inc Relay Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 223,289 shares of RLAY stock, worth $960,142. This represents 0.0% of its overall portfolio holdings.

Number of Shares

223,289

Previous 209,649 6.51%

Holding current value

$960,142

Previous $1.37 Million 15.67%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.23 - $9.51 $84,977 - $129,716	13,640 Added 6.51%	223,289 $1.58 Million
Q2 2024 Aug 13, 2024	SELL	$5.9 - $8.02 $2.05 Million - $2.79 Million	-347,647 Reduced 62.38%	209,649 $1.37 Million
Q1 2024 May 15, 2024	SELL	$7.5 - $12.07 $2.13 Million - $3.43 Million	-284,570 Reduced 33.8%	557,296 $4.63 Million
Q4 2023 Feb 14, 2024	SELL	$6.01 - $11.48 $141,769 - $270,801	-23,589 Reduced 2.73%	841,866 $9.27 Million
Q3 2023 Nov 13, 2023	SELL	$8.24 - $12.97 $173,756 - $273,498	-21,087 Reduced 2.38%	865,455 $7.28 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $1.06 Million - $1.61 Million	70,544 Added 8.65%	886,542 $14.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.16 - $24.02 $192,037 - $325,759	-13,562 Reduced 1.63%	815,998 $12.2 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $865,860 - $1.5 Million	47,917 Added 6.13%	829,560 $18.6 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $2.76 Million - $7.23 Million	207,196 Added 36.07%	781,643 $13.1 Million
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $826,830 - $1.32 Million	-40,811 Reduced 6.63%	574,447 $17.2 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $9.91 Million - $14.1 Million	381,012 Added 162.65%	615,258 $18.9 Million
Q3 2021 Nov 15, 2021	SELL	$29.75 - $37.99 $832,851 - $1.06 Million	-27,995 Reduced 10.68%	234,246 $7.39 Million
Q2 2021 Aug 16, 2021	SELL	$27.5 - $38.19 $4.49 Million - $6.23 Million	-163,210 Reduced 38.36%	262,241 $9.6 Million
Q1 2021 May 14, 2021	SELL	$32.52 - $61.53 $1.92 Million - $3.63 Million	-58,944 Reduced 12.17%	425,451 $14.7 Million
Q4 2020 Mar 01, 2021	BUY	$35.51 - $54.03 $8.16 Million - $12.4 Million	229,886 Added 90.33%	484,395 $20.1 Million
Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $8.35 Million - $11.5 Million	254,509 New	254,509 $10.8 Million

Others Institutions Holding RLAY

# of Institutions

204

Shares Held

156M

Call Options Held

207K

Put Options Held

40K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $517M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Relay Therapeutics, Inc. Transaction History